These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26338723)

  • 1. Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4.
    Hamal S; D'huys T; Rowley WF; Vermeire K; Aquaro S; Frost BJ; Schols D; Bell TW
    Org Biomol Chem; 2015 Nov; 13(42):10517-26. PubMed ID: 26338723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azamacrocyclic metal complexes as CXCR4 antagonists.
    Tanaka T; Narumi T; Ozaki T; Sohma A; Ohashi N; Hashimoto C; Itotani K; Nomura W; Murakami T; Yamamoto N; Tamamura H
    ChemMedChem; 2011 May; 6(5):834-9. PubMed ID: 21312334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor.
    Hatse S; Princen K; De Clercq E; Rosenkilde MM; Schwartz TW; Hernandez-Abad PE; Skerlj RT; Bridger GJ; Schols D
    Biochem Pharmacol; 2005 Sep; 70(5):752-61. PubMed ID: 16011832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4.
    Bridger GJ; Skerlj RT; Padmanabhan S; Martellucci SA; Henson GW; Struyf S; Witvrouw M; Schols D; De Clercq E
    J Med Chem; 1999 Sep; 42(19):3971-81. PubMed ID: 10508445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses.
    Rusconi S; Lo Cicero M; Viganò O; Sirianni F; Bulgheroni E; Ferramosca S; Bencini A; Bianchi A; Ruiz L; Cabrera C; Martinez-Picado J; Supuran CT; Galli M
    Molecules; 2009 May; 14(5):1927-37. PubMed ID: 19471212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication.
    Bridger GJ; Skerlj RT; Hernandez-Abad PE; Bogucki DE; Wang Z; Zhou Y; Nan S; Boehringer EM; Wilson T; Crawford J; Metz M; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Feb; 53(3):1250-60. PubMed ID: 20043638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of a CXCR4 targeting peptide 4DV3 as an HIV entry inhibitor and a ligand for targeted drug delivery.
    Heon Lee I; Palombo MS; Zhang X; Szekely Z; Sinko PJ
    Eur J Pharm Biopharm; 2019 May; 138():11-22. PubMed ID: 29894816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel compounds containing multiple guanide groups that bind the HIV coreceptor CXCR4.
    Wilkinson RA; Pincus SH; Shepard JB; Walton SK; Bergin EP; Labib M; Teintze M
    Antimicrob Agents Chemother; 2011 Jan; 55(1):255-63. PubMed ID: 20937786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 chemokine receptor antagonists: nickel(II) complexes of configurationally restricted macrocycles.
    Smith R; Huskens D; Daelemans D; Mewis RE; Garcia CD; Cain AN; Freeman TN; Pannecouque C; De Clercq E; Schols D; Hubin TJ; Archibald SJ
    Dalton Trans; 2012 Oct; 41(37):11369-77. PubMed ID: 22892890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new class of low molecular weight antagonists against the chemokine receptor CXCR4 having the dipicolylamine-zinc(II) complex structure.
    Tamamura H; Ojida A; Ogawa T; Tsutsumi H; Masuno H; Nakashima H; Yamamoto N; Hamachi I; Fujii N
    J Med Chem; 2006 Jun; 49(11):3412-5. PubMed ID: 16722661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.
    Lumangtad LA; Claeys E; Hamal S; Intasiri A; Basrai C; Yen-Pon E; Beenfeldt D; Vermeire K; Bell TW
    Bioorg Med Chem; 2020 Dec; 28(24):115816. PubMed ID: 33181479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection.
    Wilkinson RA; Pincus SH; Song K; Shepard JB; Weaver AJ; Labib ME; Teintze M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2197-201. PubMed ID: 23434419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication.
    Skerlj RT; Bridger GJ; Kaller A; McEachern EJ; Crawford JB; Zhou Y; Atsma B; Langille J; Nan S; Veale D; Wilson T; Harwig C; Hatse S; Princen K; De Clercq E; Schols D
    J Med Chem; 2010 Apr; 53(8):3376-88. PubMed ID: 20297846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes.
    Maples RD; Cain AN; Burke BP; Silversides JD; Mewis RE; D'huys T; Schols D; Linder DP; Archibald SJ; Hubin TJ
    Chemistry; 2016 Aug; 22(36):12916-30. PubMed ID: 27458983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
    Hegde R; Borkow G; Berchanski A; Lapidot A
    FEBS J; 2007 Dec; 274(24):6523-36. PubMed ID: 18028446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 X4 activities of polycationic "viologen" based dendrimers by interaction with the chemokine receptor CXCR4: study of structure-activity relationship.
    Asaftei S; Huskens D; Schols D
    J Med Chem; 2012 Dec; 55(23):10405-13. PubMed ID: 23157587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-lead CXCR4 antagonists with high anti-HIV activity.
    Fujii N; Tamamura H
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1198-202. PubMed ID: 11717804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and genetic characterization of a human immunodeficiency virus strain resistant to CXCR4 antagonist T134.
    Kanbara K; Sato S; Tanuma J; Tamamura H; Gotoh K; Yoshimori M; Kanamoto T; Kitano M; Fujii N; Nakashima H
    AIDS Res Hum Retroviruses; 2001 May; 17(7):615-22. PubMed ID: 11375057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.